MFAP2 is highly expressed in a wide range of malignant tumors including GBM and plays a key role in glioma cell migration, proliferation, angiogenesis and was related to malignant phenotypes and to a poor prognosis of patients with GBM (67). Here, MFAP2 is linked to central nervous system cancer.